← Back to Blog

How Is Asthma Linked to Inflammation?

Asthma is defined by inflammation, not just narrowed airways. Understanding the type 2 immune response behind most asthma explains why controller inhalers target inflammation rather than only opening the airways.

Reviewed by the Sensa Wellness editorial team. Written to reflect current, publicly available inflammation research.

The short answer

Asthma is a chronic inflammatory disease of the airways. In most people it is driven by type 2 inflammation, in which immune cells (type 2 helper T cells and innate lymphoid cells) release interleukin-4, interleukin-5, and interleukin-13. These cytokines recruit eosinophils and trigger mucus production, swelling, and airway tightening. Because this inflammation is present even between attacks, inhaled anti-inflammatory medicines are the cornerstone of asthma control.

Asthma is often pictured simply as airways that squeeze shut, but the wheezing and breathlessness are the visible end of a deeper process: ongoing inflammation in the lining of the airways. That inflammation makes the airways hyper-reactive, so triggers like allergens, cold air, exercise, or a virus provoke swelling, mucus, and muscle tightening. Understanding what kind of inflammation drives asthma explains why the most important treatments work by calming the immune response rather than only relaxing airway muscle.

Type 2 airway inflammation is an immune response in which cells release interleukin-4, interleukin-5, and interleukin-13, drawing eosinophils into the airways and causing mucus, swelling, and narrowing. It underlies the majority of asthma.

What Type of Inflammation Causes Asthma?

Most asthma is driven by type 2 inflammation. According to a 2022 review in ERJ Open Research, this response can be triggered through the innate immune system (by pollutants, viruses, or fungi activating type 2 innate lymphoid cells) and through the adaptive immune system (by allergen contact activating type 2 helper T cells). Both cell types produce the same trio of type 2 cytokines: interleukin-4 (IL-4), interleukin-5 (IL-5), and interleukin-13 (IL-13). Each has a distinct job in the inflammatory cascade, and together they generate the characteristic features of asthma.

The review explains that IL-4 and IL-13 cause B cells to switch to producing IgE antibodies, drive the release of inflammatory mediators, disrupt the airway barrier, and promote tissue remodeling. IL-13 additionally triggers goblet-cell hyperplasia and mucus production. All three cytokines help traffic eosinophils, a type of white blood cell, into airway tissue, producing the symptoms typical of asthma and related airway diseases.

The type 2 cytokines in asthma
CytokineMain effects in the airway
IL-4IgE class switching, recruits inflammatory cells, barrier disruption
IL-5Drives eosinophil production and trafficking
IL-13Mucus production, goblet-cell hyperplasia, tissue remodeling, IgE

Why Is Airway Inflammation Present Between Attacks?

Asthma inflammation does not switch off when symptoms ease. Even when someone feels well and is breathing normally, low-grade inflammation often persists in the airway lining, keeping it swollen and hyper-reactive. This is the central reason that controller (preventer) inhalers, which reduce inflammation, are taken daily and are the foundation of asthma management, while quick-relief inhalers only relax airway muscle during symptoms. Treating the underlying inflammation lowers the frequency and severity of attacks. This article is educational and does not recommend any specific medication or dose; an asthma treatment plan should be set with a clinician.

Is All Asthma Type 2 Inflammation?

Not all asthma is type 2. While type 2 inflammation drives the majority of cases, a subset of people have non-type-2 asthma, sometimes involving neutrophils rather than eosinophils, or relatively little detectable inflammation. This heterogeneity is why asthma is increasingly treated as several overlapping conditions rather than one disease, and why identifying a person's inflammatory pattern matters for choosing therapy.

Broad asthma inflammatory patterns
PatternKey feature
Type 2 (eosinophilic/allergic)IL-4/IL-5/IL-13, eosinophils; most common; often allergy-linked
Non-type-2Neutrophilic or low-inflammation; less allergy-driven

How Do Biologic Treatments Target Asthma Inflammation?

The discovery of type 2 cytokines led directly to targeted biologic therapies. The ERJ Open Research review notes that current asthma guidelines recommend add-on biologic treatments, including agents that block IgE, IL-5 or its receptor, and IL-4 receptor signaling, for people not adequately controlled by inhaled corticosteroids and long-acting bronchodilators. That these precision therapies work is powerful evidence that inflammation, and these specific cytokines, sit at the heart of asthma. Which therapy suits a given person is a clinical decision guided by their inflammatory biomarkers.

Can Lifestyle Reduce Asthma Inflammation?

Medical treatment is central to asthma, but reducing exposure to triggers supports airway health. General measures endorsed by bodies such as the American Academy of Allergy, Asthma and Immunology include avoiding known allergens and irritants (including tobacco smoke and air pollution), managing allergies, staying up to date on respiratory vaccinations, keeping active within a doctor's guidance, and maintaining a healthy weight, since obesity is associated with worse asthma control. These support, but never replace, a prescribed asthma action plan. Seek medical care for worsening symptoms, and emergency care for severe breathing difficulty.

How Common Is Asthma?

Asthma is one of the most common chronic diseases in the world, affecting more than 260 million people globally and about 25 million people in the United States, roughly one in thirteen. It is a leading chronic condition in children. Because so many people live with it, understanding that asthma is fundamentally an inflammatory disease, rather than simply twitchy airways, has broad relevance for how it is managed day to day.

What Are the Main Symptoms of Asthma?

Asthma symptoms arise when underlying airway inflammation flares into narrowing and mucus. The classic symptoms are wheezing (a whistling sound when breathing), shortness of breath, chest tightness, and coughing, which often worsen at night, early in the morning, or with exercise and triggers. Symptoms vary in frequency and severity between people, and over time in the same person, from occasional mild episodes to frequent, limiting ones. Because the symptoms come from inflamed, hyper-reactive airways, controlling the inflammation is what reduces them.

What Triggers Asthma Inflammation?

Asthma triggers are the exposures that provoke the underlying airway inflammation to flare into symptoms. They vary from person to person, which is why identifying your own triggers is a core part of management. Common categories include allergens such as pollen, dust mites, pet dander, and mold; irritants like tobacco smoke, air pollution, and strong fumes; respiratory infections; cold air; exercise; and, for some, strong emotions or stress. Because triggers set off the type 2 inflammatory response already primed in the airway, reducing exposure lowers how often that inflammation escalates.

Common asthma triggers
CategoryExamples
AllergensPollen, dust mites, pet dander, mold
IrritantsTobacco smoke, air pollution, strong fumes
InfectionsColds and other respiratory viruses
PhysicalCold air, exercise, strong emotions

What Is Airway Remodeling?

When airway inflammation persists for years without adequate control, it can lead to airway remodeling, longer-term structural changes in the airway walls. As the ERJ Open Research review notes, type 2 cytokines like IL-4 and IL-13 contribute to tissue remodeling, and IL-13 drives mucus-producing goblet cells. Over time this can thicken airway walls and make narrowing less reversible. Remodeling is a key reason that controlling inflammation early and consistently, rather than only treating attacks, is emphasized in asthma care, and why a personalized plan set with a clinician matters.

Can Asthma Be Controlled?

Asthma cannot usually be cured, but for most people it can be well controlled so that symptoms are infrequent and daily life is unaffected. Control rests on two pillars: reducing airway inflammation, typically with daily controller therapy prescribed by a clinician, and minimizing exposure to personal triggers. Regular review of symptoms and lung function guides adjustments. Good control not only relieves symptoms but also lowers the risk of attacks and long-term airway remodeling, which is why consistency matters even when you feel well.

Can You Reduce Asthma Triggers at Home?

Reducing everyday exposures at home can lower how often airway inflammation flares. Practical steps supported by asthma organizations include keeping the home smoke-free, reducing dust mites with allergen-proof bedding covers and washing bedding regularly in hot water, controlling humidity and fixing damp to limit mold, minimizing contact with pet allergens where relevant, and improving indoor air quality by avoiding strong fumes and outdoor air pollution on high-pollution days. Staying current with recommended vaccinations reduces the respiratory infections that commonly set off attacks. Maintaining a healthy weight matters too, since obesity is associated with worse asthma control and higher background inflammation. None of these replace a prescribed asthma action plan, but together they reduce the trigger load on already sensitive airways, and they often reduce the frequency of symptoms enough to notice.

Does CRP Reflect Asthma Airway Inflammation?

C-reactive protein (CRP) is a marker of systemic, whole-body inflammation, and it does not specifically measure the localized airway inflammation of asthma. A normal CRP does not mean the airways are calm, and asthma is monitored with lung function tests and airway-specific markers rather than CRP. What CRP can offer as a general wellness signal is a window into your overall inflammatory tone, which is shaped by weight, sleep, activity, and diet, the same factors that influence general health in people with asthma. Sensa is a general wellness device that lets you track CRP at home over time; it is not a diagnostic tool and does not measure or manage asthma. Learn more in our guide to what CRP is.

Sources

  • Maspero J, et al. Type 2 inflammation in asthma and other airway diseases (ERJ Open Research, 2022): doi.org
  • Cleveland Clinic, Asthma: clevelandclinic.org
  • American Academy of Allergy, Asthma & Immunology, Asthma: aaaai.org
  • NIH NHLBI, Asthma: nhlbi.nih.gov

Want a window into your overall inflammation?

Sensa is a general wellness tool that lets you measure your CRP levels at home. No needles, no clinic visit. Track your baseline over time and see how lifestyle changes move your number.

Buy Now